AB Science S.A. (EPA:AB)
1.182
-0.036 (-2.96%)
Apr 2, 2026, 5:35 PM CET
AB Science Market Cap
AB Science has a market cap or net worth of €86.22 million as of April 2, 2026. Its market cap has decreased by -4.66% in one year.
Market Cap
86.22M
Enterprise Value
100.27M
Revenue
1.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.18
Market Cap Chart
Since April 26, 2010, AB Science's market cap has decreased from 381.93M to 86.22M, a decrease of -77.42%. That is a compound annual growth rate of -8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 86.22M | -23.05% |
| Dec 31, 2025 | 112.05M | 94.70% |
| Dec 31, 2024 | 57.55M | -68.19% |
| Dec 29, 2023 | 180.92M | -45.55% |
| Dec 30, 2022 | 332.25M | -40.91% |
| Dec 31, 2021 | 562.31M | -37.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 99.72B |
| EssilorLuxottica Société anonyme | 88.27B |
| Sartorius Stedim Biotech | 16.45B |
| Ipsen | 13.75B |
| Guerbet | 114.55M |
| Innate Pharma | 108.91M |
| Crossject Société Anonyme | 107.85M |
| MaaT Pharma | 107.63M |